| [(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxymethyl]-4-hydroxyoxolan-3-yl] dihydrogen phosphate 基本信息 | |||
|---|---|---|---|
| CAS号 | 10453-52-8 | 分子式 | C19H24N7O12P |
| 分子量 | 573.40700 | 精确质量 | 573.12200 |
| PSA | N/A | LogP | N/A |
合成路线 共1页 3256-24-4
腺苷酰基-(3',5')-尿苷
→
10453-52-8
[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxymethyl]-4-hydroxyoxolan-3-yl] dihydrogen phosphate
29886-19-9
2,3-二乙酸腺苷酸酯
→
10453-52-8
[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxymethyl]-4-hydroxyoxolan-3-yl] dihydrogen phosphate
60031-83-6
adenosine 5'-phosphoroimidazolidate sodium salt
+
58-96-8
尿嘧啶核苷
→
2889-33-0
[5-(6-aminopurin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
+
3256-24-4
腺苷酰基-(3',5')-尿苷
61-19-8
5'-腺嘌呤核苷酸
→
2889-33-0
[5-(6-aminopurin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxyoxolan-2-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
+
3256-24-4
腺苷酰基-(3',5')-尿苷